Therefore, we reasonably anticipate that NFL and GFAP are likely to be significant prognostic predictors in participants with pre-existing AD pathology, primarily because these participants have a high probability of marked fluctuations in neurodegeneration, neuroinflammation, and cognitive function.
← all excerpts
Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.
1
—
—